Clinical Trials Browser

Completed × OTHER × Uveal Melanoma × Clear all

NCT05187884 2026-04-23

NADOM

Phase 2 Completed

Uveal Melanoma

NCT05628883 2026-04-02

Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma

Phase 1 Completed

Uveal Melanoma, Melanoma

NCT06861647 2026-04-01

iSITE

Uveal Melanoma

NCT01046487 2026-03-13

PALANGI3

Phase 1 Completed

DermatologicGastrointestinalSarcoma

Uveal Melanoma, Chordoma, Carcinoma, Adenoid Cystic, Neoplasms, Desmoid Tumors, Dermatofibrosarcoma, Gastrointestinal Stromal Tumors

NCT02858869 2026-03-09

Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases

Phase 1 Completed

25 enrolled 14 charts

CNSDermatologicThoracic

Uveal Melanoma, Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma

NCT02517736 2026-02-17

O-Mel-Sora

Phase 2 Completed

Uveal Melanoma

NCT04552223 2026-02-11

Nivolumab Plus Relatlimab in Patients With Metastatic Uveal Melanoma

Phase 2 Completed

27 enrolled 9 charts

Uveal Melanoma

NCT01983748 2026-01-28

Dendritic Cells Plus Autologous Tumor RNA in Uveal Melanoma

Phase 3 Completed

Uveal Melanoma

NCT04082962 2025-12-17

Dexamethasone Implant for Retinal Detachment in Uveal Melanoma

Phase 1 Completed

Uveal Melanoma

NCT01334008 2025-11-24

Study of Circulating Tumoral DNA in Metastatic Choroidal Melanoma

Phase NA Completed

Uveal Melanoma

NCT01473004 2025-11-14

SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver

Phase 2 Completed

48 enrolled 10 charts

Uveal Melanoma, Melanoma

NCT02849145 2025-09-19

ctDNA R0

Phase NA Completed

Uveal Melanoma

NCT04118062 2025-09-19

Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR)

Phase NA Completed

BreastDermatologic

Uveal Melanoma, Neoplasms, Triple Negative Breast Neoplasms

NCT04728113 2025-09-08

EARLY TOGETHER

Phase NA Completed

Uveal Melanoma

NCT05004025 2025-08-15

Single Arm Trial of Tumor-Treating Fields in Combination With Nivolumab and Ipilimumab in Metastatic Uveal Melanoma

Phase 1 Completed

Uveal Melanoma

NCT03964298 2025-08-11

imMUno

Uveal Melanoma

NCT02874040 2025-08-08

Endoresection of the Tumor Scar or Transpupillary Thermotherapy for the Treatment of Large Uveal Melanomas (Endoresection-Laser)

Phase NA Completed

Uveal Melanoma

NCT00661622 2025-05-16

Halt Growth of Liver Tumors From Uveal Melanoma With Closure of Liver Artery Following Injection of GM-CSF

Phase 2 Completed

53 enrolled 12 charts

Uveal Melanoma

NCT03922880 2025-05-15

Study of Immunotherapy Plus ADI-PEG 20 for the Treatment of Advanced Uveal Melanoma

Phase 1 Completed

Uveal Melanoma

NCT03472586 2025-04-24

Ipilimumab and Nivolumab With Immunoembolization in Treating Participants With Metastatic Uveal Melanoma in the Liver

Phase 2 Completed

14 enrolled 8 charts

Uveal Melanoma

NCT01355120 2025-04-09

DeCOG

Phase 2 Completed

Uveal Melanoma

NCT03172299 2025-03-24

PROTECT

Phase 3 Completed

Uveal Melanoma

NCT01338389 2025-02-24

Influence of Oral Treatment With Citicoline for the Prevention of Radiation Optic Neuropathy in Patients Treated for Uveal Melanomas With Proton Beam Therapy

Phase NA Completed

Uveal Melanoma

NCT02936388 2025-01-24

SirTac

Phase 2 Completed

Uveal Melanoma

NCT05169957 2024-11-05

Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I)

Phase 1 Completed

Uveal Melanoma, Melanoma

NCT04364230 2024-07-16

Mel66

Phase 1/2 Completed

Uveal Melanoma, Melanoma, Nevus

NCT01585194 2024-07-09

Nivolumab and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma

Phase 2 Completed

67 enrolled 12 charts

Uveal Melanoma

NCT02519322 2024-04-05

Neoadjuvant and Adjuvant Checkpoint Blockade

Phase 2 Completed

53 enrolled 10 charts

Uveal Melanoma, Melanoma

NCT00445965 2024-04-04

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Phase 2 Completed

78 enrolled 11 charts

CNSDermatologicGynecologicOther solid neoplasmSarcomaThoracic

Familial ependymoma, Uveal Melanoma, Astrocytoma, Brain Neoplasms, Chondrosarcoma, Ependymoma, Glioblastoma, Glioma, Lung Neoplasms, Medulloblastoma, Melanoma, Neoplasm Metastasis, Neuroblastoma, Oligodendroglioma, Ovarian Neoplasms, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Osteosarcoma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Neuroectodermal Tumors, Primitive, Neoplasms, Neuroepithelial, Glioma, Subependymal, Gliosarcoma, Rhabdoid Tumor, Optic Nerve Glioma, Small Cell Lung Carcinoma, Desmoplastic Small Round Cell Tumor

NCT02875652 2024-01-31

ctDNA MU

Phase NA Completed

Uveal Melanoma

NCT02223819 2023-12-06

Crizotinib in High-Risk Uveal Melanoma Following Definitive Therapy

Phase 2 Completed

34 enrolled 9 charts

Uveal Melanoma

NCT03207347 2023-09-15

A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)

Phase 2 Completed

37 enrolled 15 charts

DermatologicGastrointestinalGenitourinaryOther solid neoplasmThoracic

Uveal Melanoma, Carcinoma, Renal Cell, Mesothelioma, Cholangiocarcinoma

NCT02768766 2023-08-31

Intermittent Selumetinib for Uveal Melanoma

Phase 1 Completed

Uveal Melanoma, Melanoma

NCT02273219 2023-08-15

Trial of AEB071 in Combination With BYL719 in Patients With Melanoma

Phase 1 Completed

Uveal Melanoma, Melanoma

NCT01955941 2023-06-26

Vascular Response to Brachytherapy Using Functional OCT

Uveal Melanoma

NCT02843386 2022-08-31

FOTEADJ

Phase 3 Completed

Uveal Melanoma

NCT02626962 2022-03-22

GEM1402

Phase 2 Completed

Uveal Melanoma, Melanoma

NCT01460810 2022-03-07

Safety and Efficacy of Silicone Oil Tamponade for Surgical Attenuation of Radiation Damage in Choroidal Melanoma

Phase NA Completed

Uveal Melanoma

NCT00344799 2021-03-29

Cytogenetic Study of Ocular Melanoma

Uveal Melanoma

NCT04577742 2020-10-08

Uveal Melanoma and Brachytheraphy: Long-term Outcomes.

Uveal Melanoma

NCT01005472 2020-08-03

Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma

Phase 1 Completed

Uveal Melanoma, Melanoma

NCT01773655 2020-07-01

Clinical and Histopathologic Characteristics of BAP1 Mutations

DermatologicGastrointestinalGenitourinaryOther solid neoplasmThoracic

Mesothelioma, Malignant, Uveal Melanoma, Carcinoma, Renal Cell, Cholangiocarcinoma

NCT02158520 2020-01-21

Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery

Phase 2 Completed

24 enrolled 10 charts

Uveal Melanoma, Melanoma

NCT01551459 2019-10-29

SUAVE

Phase 2 Completed

Uveal Melanoma, Melanoma, Neoplasm Metastasis

NCT00254397 2019-10-16

Melanoma Vaccine With Peptides and Leuprolide

Phase 2 Completed

98 enrolled 11 charts

Uveal Melanoma, Eye Neoplasms, Melanoma, Skin Neoplasms

NCT01100528 2019-02-26

Dacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic Imbalance

Phase 2 Completed

38 enrolled 10 charts

Uveal Melanoma

NCT01200238 2018-10-18

STA-9090(Ganetespib) in Metastatic Ocular Melanoma

Phase 2 Completed

17 enrolled 12 charts

Uveal Melanoma

NCT01961115 2018-06-08

Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma

Phase 2 Completed

11 enrolled 12 charts

Uveal Melanoma, Melanoma

NCT01893099 2018-04-23

Sorafenib and Radioembolization With Sir-Spheres® for the Treatment of Metastatic Ocular Melanoma

Phase 1 Completed

Uveal Melanoma

NCT01034787 2017-10-27

Study of AntiCTLA4 in Patients With Unresectable or Metastatic Uveal Melanoma

Phase 2 Completed

Uveal Melanoma, Neoplasm Metastasis